Selective recovery of glyphosine from glyphosate mother liquor using a modified biosorbent: Competitive substitution adsorption.

Here, an easy to prepare, environmentally friendly, and highly efficient biosorbent was synthesized for the selective recovery of glyphosine from glyphosate mother liquor. Batch adsorption and continuous fixed-bed column experiments were conducted to determine its adsorption properties and evaluate its potential towards practical applications. The results showed that the biosorbent exhibited a fast adsorption rate and high adsorption capacity (296.1 mg/g) toward glyphosine. Further, the biosorbent performed better under acidic conditions, and was easily regenerated using an alkaline solution, maintaining a high removal efficiency even after 5 adsorption-desorption cycles. Competitive adsorption experiments in binary and ternary systems revealed that the biosorbent showed a higher adsorption affinity toward the target glyphosine compared with glyphosate and phosphorous acid (which are the other main constituents of glyphosate mother liquor), enabling the selective recycling of glyphosine. These observations were further supported through density functional theory (DFT) calculations of the adsorption energy. Moreover, fixed-bed column experiments showed that the prepared biosorbent could maintain its high performance in actual glyphosate mother liquor. Fourier transform infrared (FTIR) spectroscopy and X-ray photoelectron spectroscopy (XPS) analyses revealed that the adsorption mechanism is strongly associated with electrostatic attraction and hydrogen bonding between -NH3+ and glyphosine. Overall, the prepared biosorbent can be considered as an excellent candidate for the selective recovery of glyphosine from complicated industrial wastewater systems.

Genetic screening of a pedigree with osteogenesis imperfecta type â and identification of a novel mutation in COL1A2 pathogenic gene.

To uncover the molecular pathogenic mechanism of congenital osteogenesis imperfecta (OI) type I, all the 103 exons of the COL1A1 (Collagen, type Ⅰ, alpha 1) and COL1A2 (Collagen, type Ⅰ, alpha 2) genes in a child with OI type Ⅰ were screened using PCR-DNA direct sequencing. The results showed no pathological mutation in COL1A1 gene, but a novel mutation c.946G>T/p.G316C in the exon 19 of COL1A2 gene, which was inherited from her father. This mutation was not found in her mother and other six phenotypically normal relatives. By denaturing high performance liquid chromatography (DHPLC) screening, the abnormal double-peak was visualized in PCR products of exon 19 of COL1A2 gene in the proband and her father, while the normal single-peak was shown in those of her mother and all the healthy controls. Using allele specific amplification (ASA) screening, a specific band of 391 bp in COL1A2 exon 19 was amplified only in the proband and her father, but not in other samples. The amino acid encoded by the mutation site is evolutionarily highly conserved, and this mutation was a "damaging" or "probably damaging" factor to OI type Ⅰ, based on the predicting results using SIFT and Polyphen-2 softwares. In conclusion, the novel c.946G>T/p.G316C mutation in COL1A2 gene is a pathogenic mutation that could result in OI type Ⅰ. If the couple wants to get pregnant again, it is necessary to screen the mutation site in COL1A2 gene through the prenatal genetic diagnosis in the first trimester or through preimplantation genetic diagnosis (PGD) in the progestation.